Radiofrequency echographic multi spectrometry (REMS): description of the method and perspective for its usage in clinical practice

Osteoporosis is a systemic skeletal disease characterized by decreased bone mass and changes in tissue microarchitecture. The occurrence of post-traumatic fractures due to osteoporosis leads to a decrease in the quality and life expectancy of the affected population, as well as to an increase in health care costs for the treatment and rehabilitation of these patients, which makes osteoporosis a medical and social problem of the 21st century. In addition to prevention, early and complete diagnosis of osteoporosis is crucial for the initiation of timely treatment. Along with existing methods for osteoporosis diagnostics before a fracture develops: fracture risk assessment (FRAX) and bone mineral density (BMD) measurement by dual-energy X-ray osteodensitometry (DXA), new technologies are constantly being developed, including those that take into account the low availability and low mobility of DXA. An innovative method for assessing bone density and the risk of fractures is radiofrequency echographic multi spectrometry (REMS) - a non-ionizing method for scanning axial areas of the skeleton - the spine and hip. This review summarizes the studies conducted and accumulated knowledge on the use of REMS in clinical practice

1. Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: a compendium of aetiology, diagnosis and management. Archives of Osteoporosis. 2013;8(1):1-36. doi: https://doi.org/10.1007/s11657-013-0159-0

2. Cummings SR, Melton LJ. Epidemiology and Outcomes of Osteoporotic Fractures. The Lancet. 2002;359(9319):1761-1767. doi: https://doi.org/10.1016/S0140-6736(02)08657-9

3. Lesnyak OM, Yershova OB, Belova KYu, et al. Еpidemiology of osteoporotic fractures in the russian federation and the russian model of FRAX. Osteoporosis and Bone Diseases. 2014;17(3):3-8. (In Russ.) doi: https://doi.org/10.14341/osteo201433-8

4. Belaya ZhE, Belova KYu, Biryukova EV, et al. Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis. Osteoporosis and Bone Diseases. 2021;24(2):4-47. (In Russ.) doi: https://doi.org/10.14341/osteo12930

5. Sharashkina NV, Naumov AV, Dudinskaya EN, et al. Consensus of experts: Diagnosis of osteoporosis and sarcopenia in elderly and senile patients. Therapy. (In Russ.) doi: https://doi.org/10.18565/therapy.2023.10.7-20

6. Belaya Z, Rozhinskaya L, Dedov I, et al. A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis. Osteoporos International. 2023;34(3):429-447. doi: https://doi.org/10.1007/s00198-022-06667-6

7. Sarecka-Hujar B. The Role of DXA in the Assessment of Bone Mineral Density. Wiadomości Lekarskie. 2016;69(1):57-63

8. Beck T. Measuring the structural strength of bones with dualenergy X-ray absorptiometry: principles, technical limitations, and future possibilities. Osteoporos International. 2003;14(5):81–8. doi: https://doi.org/10.1007/s00198-003-1478-0

9. Petryaykin AV, Nizovtsova LA, Artyukova ZR, et al. Osteodensitometry: methodological recommendations. The series «The best practices of radiation and instrumental diagnostics». Issue 88. 2nd ed., reprint. And additional information: GBUZ «NPCC dit DZM». 2020; 60 (In Russ.)

10. Kanis JA, Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporos International. 16(3):229– 238. doi: https://doi.org/10.1007/s00198-004-1811-25

11. Lesnyak OM, Baranova IA, Belova KYu, et al. Osteoporosis in Russian Federation: Epidemiology, Socio-Medical and Economical Aspects (Review). Travmatologiya i ortopediya Rossii [Traumatology and orthopedics of russia. 2018;24(1):155-168. (in Russ). doi: https://doi.org/10.21823/2311-2905-2018-24-1-155-168

12. Nicholas R Fuggle, Elizabeth M Curtis, Kate A Ward et al. Fracture prediction, imaging and screening in osteoporosis. Nature Reviews Endocrinology. 2019;(15):535–547. doi: https://doi.org/10.1038/s41574-019-0220-8

13. Diez-Perez A, Brandi ML, Al-Daghri N, et al. Radiofrequency echographic multispectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO). Aging Clin Exp Res. 2019;(31):1375–1389. doi: https://doi.org/10.1007/s40520-019-01294-4

14. Conversano F, Franchini R, Greco A, et al. A novel ultrasound methodology for estimating spine mineral density. Ultrasound Med. Biol. 2015;41(1):281–300. doi: https://doi.org/10.1016/j.ultrasmedbio.2014.08.017

15. Casciaro S, Peccarisi M, Pisani P, et al. An advanced quantitative echosound methodology for femoral neck densitometry. Ultrasound Med. Biol. 2016;42(60):1337–1356. doi: https://doi.org/10.1016/j.ultrasmedbio.2016.01.024

16. Casciaro S, Conversano F, Pisani P, et al. New perspectives in echographic diagnosis of osteoporosis on hip and spine. Clin. Cases Miner. Bone Metab. 2015;12(2):142–150. doi: https://doi.org/10.11138/ccmbm/2015.12.2.142

17. Lesnyak OM. A new method for assessing bone tissue strength: radiofrequency echographic multispectrometry. Effective pharmacotherapy. 2020;16(19):38-44. (In Russ.) doi: https://doi.org/10.33978/2307-3586-2020-16-19-38-44

18. Caffarelli C, Tomai Pitinica MD, Francolini V, et al. REMS technique: future perspectives in an Academic Hospital. Clin. Cases Miner. Bone Metab. 2018;15(2):163–165. doi: https://doi.org/10.11138/ccmbm/2018.15.2.163

19. Greco A, Pisani P, Conversano F, Soloperto G. Ultrasound fragility score: an innovative approach for the assessment of bone fragility. Measurement. 2017;101:236–242. doi: https://doi.org/10.1016/j.measurement.2016.01.033

20. Pisani P, Greco A, Conversano F, et al. A quantitative ultrasound approach to estimate bone fragility: a first comparison with dual X-ray absorptiometry. Measurement. 2017;101:243–249. doi: https://doi.org/10.1016/j.измерение.2016.07.033

21. Ivanov SN. REMS — densitometry. Expanding the possibilities of diagnosing and predicting fracture risks. Opinion Leader. 2021;45(№4)78-87. (In Russ.)

22. Sergio Casciaro, Marco Peccarisi , Paola Pisan, et al. An Advanced Quantitative Echosound Methodology for Femoral Neck Densitometry. Ultrasound in Medicine Biology. 2016;42(6):1337-56. doi: https://doi.org/10.1016/j.ultrasmedbio.2016.01.024

23. Cortet B, Dennison E, Diez-Perez A, et al. Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context. Bone. 2021. doi: https://doi.org/10.1016/j.bone.2020.115786

24. Adami G, Arioli G, Bianchi G, et al. Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study. Bone. 2020;134:115297. doi: https://doi.org/10.1016/j.bone.2020.115297

25. Paola Pisani , Francesco Conversano , Maurizio Muratore, et al. Fragility Score: a REMS-based indicator for the prediction of incident fragility fractures at 5 years. Aging Clin Exp Res. 2023;35(4):763-773. doi: https://doi.org/10.1007/s40520-023-02358-2

26. M Di Paola, D Gatti, O Viapiana, et al. Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck. Osteoporos Int. 2019;30(2):391-402. doi: https://doi.org/10.1007/s00198-018-4686-3

27. Lalli P, Claudia Mautino, Chiara Busso, et al. Reproducibility and accuracy of the Radiofrequency Echographic Multi-spectrometry for femoral Mineral density estimation and discriminative power of the femoral fragility score in patients with primary and disuse-related osteoporosis. J Clin Med 2022; 11(13):3761. doi: https://doi.org/10.3390/jcm11133761

28. Picke AK, Campbell G, Napoli N, et al. Update on the Impact of Type 2 Diabetes Mellitus on Bone Metabolism and Material Properties. Endocr Connect. 2019;8(3):55–70. doi: https://doi.org/10.1530/EC-18-0456

29. Carla Caffarelli , Maria Dea Tomai Pitinca , Antonella Al Refaie. Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes. Aging clinical and experimental research. 2022;34(1):121-127. doi: https://doi.org/10.1007/s40520-021-01889-w

30. Fiorella Anna Lombardi, Paola Pisani, Francesco Conversano. REMS technology for the assessment of the effect of dmt2 on bone health. Annals of the Rheumatic Diseases. 2024;83:1399-1399. doi: https://doi.org/10.1136/annrheumdis-2024-eular.2241

31. Rolla M, Halupczok-Zyła J, Jawiarczyk-Przybyłowska A, et al. Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in acromegaly patients. Endokrynol. Pol. 2020;71:524–531. doi: https://doi.org/10.5603/EP.a2020.0056

32. Adami Giovanni, Brandi Maria Luisa, Caffarelli Carla. Bone health status evaluation in men by means of REMS technology. Aging clinical and experimental research. 2024;36(1):74. doi: https://doi.org/10.1007/s40520-024-02728-4

33. Adolfo Diez-Perez , Maria Luisa Brandi , Nasser Al-Daghri. Radiofrequency echographic multi-spectrometry for the invivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging clinical and experimental research. 2019;31 (10): 1375-1389. doi: https://doi.org/10.1007/s40520-019-01294-4